##  [LLNL and BioVind achieve diagnostics milestone](/node/927) 

  

  Submitted by Anonymous (not verified) on Tue, 11/19/2024 - 08:57 

 [Read More](https://www.llnl.gov/article/52036/llnl-biovind-achieve-diagnostics-milestone)

 ![BioID device instrument and consumables](/sites/ipo/files/styles/scaled_300w/public/2025-09/Bio%20test_final_875_500.jpg?itok=4m3eGopg)

 



Technology designed to aid on-the-field diagnostics for military applications is gaining a wider reach as [Lawrence Livermore National Laboratory](https://www.llnl.gov/) (LLNL) and [BioVind, LLC](https://www.biovind.com/) achieved a milestone in their partnership: the exclusive licensing of LLNL pathogen diagnostics technology focused on oil and gas applications.

The technology, called BioID, is a rapid and portable molecular diagnostics platform that can detect up to 18 target DNA or RNA sequences from a single sample in 30 to 60 minutes. BioID uses an isothermal amplification technique to detect pathogen nucleic acid.



Technology Portfolio

[Life Sciences, Biotech, and Healthcare](/portfolios/life-sciences-biotech-healthcare)